Feb 24, 2022 / 04:45PM GMT
Joanne Karen Wuensch - Citigroup Inc., Research Division - MD
Thank you, everybody, and I can still say good morning for another 15 minutes. But I'm Joanne Wuensch, the Citi MedTech analyst, for those of you who don't know me. I'm very pleased for this session to have the management team from Pulmonx, both Glen French and Derrick Sung, join us. So thank you for joining us.
Glendon E. French - Pulmonx Corporation - CEO, President & Director
Thank you.
Questions and Answers:
Joanne Karen Wuensch - Citigroup Inc., Research Division - MDI have a whole list of questions here, and I can trash them now because last evening, you -- some may call it pull the band-aid off. Some might say conservatively. I'd be curious your view, updated everybody on guidance. So I think that's where we should start.
Glendon E. French - Pulmonx Corporation - CEO, President & Director
It's been a little buzz around the guidance. So, yes. So for those who might be new to our story, we're
Trustpilot
